Novavax
NVAX
#5380
Rank
A$2.30 B
Marketcap
A$14.03
Share price
2.96%
Change (1 day)
35.24%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of March 2026 : A$0.42 Billion

According to Novavax's latest financial reports the company's total debt is A$0.42 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$0.37 B0.28%
2024-12-31A$0.37 B10.17%
2023-12-31A$0.33 B-58.38%
2022-12-31A$0.80 B29.01%
2021-12-31A$0.62 B2.89%
2020-12-31A$0.60 B32.39%
2019-12-31A$0.45 B1.47%
2018-12-31A$0.45 B11.32%
2017-12-31A$0.40 B-7.25%
2016-12-31A$0.43 B80837.61%
2015-12-31A$0.54 M-55.54%
2014-12-31A$1.21 M-42.17%
2013-12-31A$2.1 M81.86%
2012-12-31A$1.15 M271.54%
2011-12-31A$0.31 M-20.75%
2010-12-31A$0.39 M-27.21%
2009-12-31A$0.54 M-98.33%
2008-12-31A$32.46 M24.79%
2007-12-31A$26.02 M-11.55%
2006-12-31A$29.41 M-29.5%
2005-12-31A$41.72 M-13.12%
2004-12-31A$48.02 M-15.34%
2003-12-31A$56.72 M-22.81%
2002-12-31A$73.48 M9.23%
2001-12-31A$67.28 M88.09%
2000-12-31A$35.77 M23405.79%
1999-12-31A$0.15 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
A$67.69 B 15,828.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$91.79 B 21,499.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$48.85 B 11,395.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$36.34 B 8,453.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$1.49 B 251.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$2.74 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$65.92 M-84.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A$2.16 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$1.17 B 177.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.95 B 124.74%๐Ÿ‡บ๐Ÿ‡ธ USA